Report Detail

Request for Sample of this report

Other Global Cell-Free DNA (cfDNA) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4598228
    • |
  • 02 July, 2024
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Cell-Free DNA (cfDNA) Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.
The Global Info Research report includes an overview of the development of the Cell-Free DNA (cfDNA) Testing industry chain, the market status of Hospital (Donor-Derived Cell-Free DNA (DdcfDNA), Circulating Cell-Free Tumor DNA (CtDNA)), Ambulatory Surgical Centers (Donor-Derived Cell-Free DNA (DdcfDNA), Circulating Cell-Free Tumor DNA (CtDNA)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell-Free DNA (cfDNA) Testing.
Regionally, the report analyzes the Cell-Free DNA (cfDNA) Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell-Free DNA (cfDNA) Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell-Free DNA (cfDNA) Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell-Free DNA (cfDNA) Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Donor-Derived Cell-Free DNA (DdcfDNA), Circulating Cell-Free Tumor DNA (CtDNA)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell-Free DNA (cfDNA) Testing market.
Regional Analysis: The report involves examining the Cell-Free DNA (cfDNA) Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell-Free DNA (cfDNA) Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell-Free DNA (cfDNA) Testing:
Company Analysis: Report covers individual Cell-Free DNA (cfDNA) Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell-Free DNA (cfDNA) Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Ambulatory Surgical Centers).
Technology Analysis: Report covers specific technologies relevant to Cell-Free DNA (cfDNA) Testing. It assesses the current state, advancements, and potential future developments in Cell-Free DNA (cfDNA) Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell-Free DNA (cfDNA) Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell-Free DNA (cfDNA) Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Market segment by Application
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
Market segment by players, this report covers
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell-Free DNA (cfDNA) Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell-Free DNA (cfDNA) Testing, with revenue, gross margin and global market share of Cell-Free DNA (cfDNA) Testing from 2019 to 2024.
Chapter 3, the Cell-Free DNA (cfDNA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cell-Free DNA (cfDNA) Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell-Free DNA (cfDNA) Testing.
Chapter 13, to describe Cell-Free DNA (cfDNA) Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cell-Free DNA (cfDNA) Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell-Free DNA (cfDNA) Testing by Type
    • 1.3.1 Overview: Global Cell-Free DNA (cfDNA) Testing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cell-Free DNA (cfDNA) Testing Consumption Value Market Share by Type in 2023
    • 1.3.3 Donor-Derived Cell-Free DNA (DdcfDNA)
    • 1.3.4 Circulating Cell-Free Tumor DNA (CtDNA)
    • 1.3.5 Cell-Free Fetal DNA (NIPT)
  • 1.4 Global Cell-Free DNA (cfDNA) Testing Market by Application
    • 1.4.1 Overview: Global Cell-Free DNA (cfDNA) Testing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Ambulatory Surgical Centers
    • 1.4.4 Cancer Research Institutes
  • 1.5 Global Cell-Free DNA (cfDNA) Testing Market Size & Forecast
  • 1.6 Global Cell-Free DNA (cfDNA) Testing Market Size and Forecast by Region
    • 1.6.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cell-Free DNA (cfDNA) Testing Market Size by Region, (2019-2030)
    • 1.6.3 North America Cell-Free DNA (cfDNA) Testing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cell-Free DNA (cfDNA) Testing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cell-Free DNA (cfDNA) Testing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Agilent Technology
    • 2.1.1 Agilent Technology Details
    • 2.1.2 Agilent Technology Major Business
    • 2.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.1.4 Agilent Technology Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Agilent Technology Recent Developments and Future Plans
  • 2.2 Allenex
    • 2.2.1 Allenex Details
    • 2.2.2 Allenex Major Business
    • 2.2.3 Allenex Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.2.4 Allenex Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Allenex Recent Developments and Future Plans
  • 2.3 Biocept
    • 2.3.1 Biocept Details
    • 2.3.2 Biocept Major Business
    • 2.3.3 Biocept Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.3.4 Biocept Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Biocept Recent Developments and Future Plans
  • 2.4 Biodesix
    • 2.4.1 Biodesix Details
    • 2.4.2 Biodesix Major Business
    • 2.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.4.4 Biodesix Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Biodesix Recent Developments and Future Plans
  • 2.5 CareDx
    • 2.5.1 CareDx Details
    • 2.5.2 CareDx Major Business
    • 2.5.3 CareDx Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.5.4 CareDx Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 CareDx Recent Developments and Future Plans
  • 2.6 Guardant Health
    • 2.6.1 Guardant Health Details
    • 2.6.2 Guardant Health Major Business
    • 2.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.6.4 Guardant Health Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Guardant Health Recent Developments and Future Plans
  • 2.7 Illumania
    • 2.7.1 Illumania Details
    • 2.7.2 Illumania Major Business
    • 2.7.3 Illumania Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.7.4 Illumania Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Illumania Recent Developments and Future Plans
  • 2.8 Invited
    • 2.8.1 Invited Details
    • 2.8.2 Invited Major Business
    • 2.8.3 Invited Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.8.4 Invited Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Invited Recent Developments and Future Plans
  • 2.9 Natera
    • 2.9.1 Natera Details
    • 2.9.2 Natera Major Business
    • 2.9.3 Natera Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.9.4 Natera Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Natera Recent Developments and Future Plans
  • 2.10 Quest Diagnostics
    • 2.10.1 Quest Diagnostics Details
    • 2.10.2 Quest Diagnostics Major Business
    • 2.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.10.4 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.11 Roche Holdings
    • 2.11.1 Roche Holdings Details
    • 2.11.2 Roche Holdings Major Business
    • 2.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.11.4 Roche Holdings Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Roche Holdings Recent Developments and Future Plans
  • 2.12 Sequenom
    • 2.12.1 Sequenom Details
    • 2.12.2 Sequenom Major Business
    • 2.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.12.4 Sequenom Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Sequenom Recent Developments and Future Plans
  • 2.13 Trovagene
    • 2.13.1 Trovagene Details
    • 2.13.2 Trovagene Major Business
    • 2.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Product and Solutions
    • 2.13.4 Trovagene Cell-Free DNA (cfDNA) Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Trovagene Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell-Free DNA (cfDNA) Testing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cell-Free DNA (cfDNA) Testing by Company Revenue
    • 3.2.2 Top 3 Cell-Free DNA (cfDNA) Testing Players Market Share in 2023
    • 3.2.3 Top 6 Cell-Free DNA (cfDNA) Testing Players Market Share in 2023
  • 3.3 Cell-Free DNA (cfDNA) Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Cell-Free DNA (cfDNA) Testing Market: Region Footprint
    • 3.3.2 Cell-Free DNA (cfDNA) Testing Market: Company Product Type Footprint
    • 3.3.3 Cell-Free DNA (cfDNA) Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell-Free DNA (cfDNA) Testing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cell-Free DNA (cfDNA) Testing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cell-Free DNA (cfDNA) Testing Consumption Value by Type (2019-2030)
  • 6.2 North America Cell-Free DNA (cfDNA) Testing Consumption Value by Application (2019-2030)
  • 6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Country
    • 6.3.1 North America Cell-Free DNA (cfDNA) Testing Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cell-Free DNA (cfDNA) Testing Consumption Value by Type (2019-2030)
  • 7.2 Europe Cell-Free DNA (cfDNA) Testing Consumption Value by Application (2019-2030)
  • 7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country
    • 7.3.1 Europe Cell-Free DNA (cfDNA) Testing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 7.3.3 France Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region
    • 8.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Consumption Value by Region (2019-2030)
    • 8.3.2 China Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 8.3.5 India Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cell-Free DNA (cfDNA) Testing Consumption Value by Type (2019-2030)
  • 9.2 South America Cell-Free DNA (cfDNA) Testing Consumption Value by Application (2019-2030)
  • 9.3 South America Cell-Free DNA (cfDNA) Testing Market Size by Country
    • 9.3.1 South America Cell-Free DNA (cfDNA) Testing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country
    • 10.3.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cell-Free DNA (cfDNA) Testing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cell-Free DNA (cfDNA) Testing Market Drivers
  • 11.2 Cell-Free DNA (cfDNA) Testing Market Restraints
  • 11.3 Cell-Free DNA (cfDNA) Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cell-Free DNA (cfDNA) Testing Industry Chain
  • 12.2 Cell-Free DNA (cfDNA) Testing Upstream Analysis
  • 12.3 Cell-Free DNA (cfDNA) Testing Midstream Analysis
  • 12.4 Cell-Free DNA (cfDNA) Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cell-Free DNA (cfDNA) Testing. Industry analysis & Market Report on Cell-Free DNA (cfDNA) Testing is a syndicated market report, published as Global Cell-Free DNA (cfDNA) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cell-Free DNA (cfDNA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo